Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris

A previously developed and centrally validated MammaPrint® (MP) and BluePrint® (BP) targeted RNA next-generation sequencing (NGS) kit was implemented and validated in two large academic European hospitals. Additionally, breast cancer molecular subtypes by MP and BP RNA sequencing were compared with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Oncol
Main Authors: Slembrouck, Laurence, Darrigues, Lauren, Laurent, Cecile, Mittempergher, Lorenza, Delahaye, Leonie JMJ, Vanden Bempt, Isabelle, Vander Borght, Sara, Vliegen, Liesbet, Sintubin, Petra, Raynal, Virginie, Bohec, Mylene, Reyes, Cécile, Rapinat, Audrey, Helsmoortel, Céline, Jongen, Lynn, Hoste, Griet, Neven, Patrick, Wildiers, Hans, Smeets, Ann, Nevelsteen, Ines, Punie, Kevin, Van Nieuwenhuysen, Els, Han, Sileny, Vincent Salomon, Anne, Laas Faron, Enora, Cynober, Timothé, Gentien, David, Baulande, Sylvain, Snel, Mireille HJ, Witteveen, Anke T, Neijenhuis, Sari, Glas, Annuska M, Reyal, Fabien, Floris, Giuseppe
Formato: Artigo
Idioma:Inglês
Publicado em: Neoplasia Press 2019
Assuntos:
Original article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6742807/
https://ncbi.nlm.nih.gov/pubmed/31513983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2019.08.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados